Urgent need for a validated tumor response evaluation system for use in immunotherapy
β Scribed by Hori, A; Kami, M; Kim, S-W; Murashige, N; Sakiyama, M; Kojima, R; Hamaki, T; Makimoto, A; Miyakoshi, S; Masuo, S
- Book ID
- 110014034
- Publisher
- Nature Publishing Group
- Year
- 2003
- Tongue
- English
- Weight
- 86 KB
- Volume
- 33
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## BACKGROUND. Although aging is one of the most important risk factors for cancer, elderly patients tend to be excluded from cancer clinical trials, only on the basis of chronologic age. Performance Status (PS) has been used widely to select adult patients for entry into clinical trials, but it d
## Abstract The genetic modification of tumor cells and delivery of cytokines have been proposed as useful strategies in the development of antiβtumor vaccines; however, a number of factors limit their use in clinical settings. To facilitate vaccine development, we explored the possibility of modif